• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Why are we afraid of Acinetobacter baumannii?

作者信息

Perez Federico, Endimiani Andrea, Bonomo Robert A

出版信息

Expert Rev Anti Infect Ther. 2008 Jun;6(3):269-71. doi: 10.1586/14787210.6.3.269.

DOI:10.1586/14787210.6.3.269
PMID:18588489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4085750/
Abstract
摘要

相似文献

1
Why are we afraid of Acinetobacter baumannii?我们为什么害怕鲍曼不动杆菌？
Expert Rev Anti Infect Ther. 2008 Jun;6(3):269-71. doi: 10.1586/14787210.6.3.269.
2
Are we closing in on an "elusive enemy"? The current status of our battle with Acinetobacter baumannii.我们正在逼近一个“难以捉摸的敌人”吗？我们与鲍曼不动杆菌战斗的当前状况。
Virulence. 2011 Mar-Apr;2(2):86-90. doi: 10.4161/viru.2.2.15748.
3
Acinetobacter baumannii resistant to everything: what should we do?对所有药物均耐药的鲍曼不动杆菌：我们该怎么办？
Clin Microbiol Infect. 2011 Jul;17(7):955-6. doi: 10.1111/j.1469-0691.2011.03566.x.
4
Global challenge of multidrug-resistant Acinetobacter baumannii.多重耐药鲍曼不动杆菌的全球挑战
Antimicrob Agents Chemother. 2007 Oct;51(10):3471-84. doi: 10.1128/AAC.01464-06. Epub 2007 Jul 23.
5
Advances in the way of dealing with antibiotic exposure in studies assessing risk factors for drug-resistant pathogens.在评估耐药病原体风险因素的研究中，处理抗生素暴露方式的进展。
Diagn Microbiol Infect Dis. 2009 May;64(1):102; author reply 103. doi: 10.1016/j.diagmicrobio.2009.01.013. Epub 2009 Feb 18.
6
[Carbapenem resistance and Acinetobacter baumannii].[碳青霉烯类耐药与鲍曼不动杆菌]
Enferm Infecc Microbiol Clin. 2004 May;22(5):259-61. doi: 10.1016/s0213-005x(04)73083-9.
7
Clonal characteristics of Acinetobacter baumannii isolated from cerebrospinal fluid in a west China hospital.中国西部某医院脑脊液分离鲍曼不动杆菌的克隆特征
J Med Microbiol. 2013 Oct;62(Pt 10):1631-1633. doi: 10.1099/jmm.0.053975-0. Epub 2013 Jul 25.
8
Importation of multidrug-resistant Acinetobacter spp infections with casualties from Iraq.伊拉克输入性多重耐药不动杆菌属感染并造成人员伤亡
Lancet Infect Dis. 2006 Jun;6(6):317-8. doi: 10.1016/S1473-3099(06)70471-6.
9
Acinetobacter baumannii: an emerging opportunistic pathogen.鲍曼不动杆菌：一种新兴的机会致病菌。
Virulence. 2012 May 1;3(3):243-50. doi: 10.4161/viru.19700.
10
Evaluation of Risk Factors and Empiric Antimicrobial Therapy for Acinetobacter baumannii Bacteremia and Impact on Patient Outcomes.鲍曼不动杆菌血症的危险因素评估、经验性抗菌治疗及其对患者预后的影响
Am J Ther. 2019 Nov/Dec;26(6):e778-e780. doi: 10.1097/MJT.0000000000000949.

引用本文的文献

1
Healthcare Equipment and Personnel Reservoirs of Carbapenem-Resistant Epidemic Clones in Intensive Care Units in a Tunisian Hospital.突尼斯一家医院重症监护病房中耐碳青霉烯类流行克隆的医疗设备及人员储存库
Microorganisms. 2023 Oct 26;11(11):2637. doi: 10.3390/microorganisms11112637.
2
Designing of multi-epitope peptide vaccine against Acinetobacter baumannii through combined immunoinformatics and protein interaction-based approaches.通过联合免疫信息学和基于蛋白质相互作用的方法设计针对鲍曼不动杆菌的多表位肽疫苗。
Immunol Res. 2023 Aug;71(4):639-662. doi: 10.1007/s12026-023-09374-4. Epub 2023 Apr 6.
3
Structure of the 70S Ribosome from the Human Pathogen Acinetobacter baumannii in Complex with Clinically Relevant Antibiotics.人病原体鲍曼不动杆菌与临床相关抗生素复合物的 70S 核糖体结构。
Structure. 2020 Oct 6;28(10):1087-1100.e3. doi: 10.1016/j.str.2020.08.004. Epub 2020 Aug 27.
4
Lung tissue microbial profile in lung cancer is distinct from emphysema.肺癌中的肺组织微生物谱与肺气肿不同。
Am J Cancer Res. 2018 Sep 1;8(9):1775-1787. eCollection 2018.
5
Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase.基于结构的硼酸作为不动杆菌衍生头孢菌素酶-7（一种独特的C类β-内酰胺酶）抑制剂的分析
ACS Infect Dis. 2018 Mar 9;4(3):325-336. doi: 10.1021/acsinfecdis.7b00152. Epub 2017 Dec 8.
6
Complexity of Complement Resistance Factors Expressed by Needed for Survival in Human Serum.人类血清中生存所需的补体抗性因子表达的复杂性。
J Immunol. 2017 Oct 15;199(8):2803-2814. doi: 10.4049/jimmunol.1700877. Epub 2017 Aug 30.
7
Contribution of the A1S_0114 Gene to the Interaction with Eukaryotic Cells and Virulence.A1S_0114基因对与真核细胞相互作用及毒力的贡献。
Front Cell Infect Microbiol. 2017 Apr 3;7:108. doi: 10.3389/fcimb.2017.00108. eCollection 2017.
8
Exploring the potential of boronic acids as inhibitors of OXA-24/40 β-lactamase.探索硼酸作为OXA-24/40β-内酰胺酶抑制剂的潜力。
Protein Sci. 2017 Mar;26(3):515-526. doi: 10.1002/pro.3100. Epub 2017 Feb 23.
9
Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS III.为抗生素治疗决策提供信息：评估快速分子诊断方法以确定不动杆菌属对碳青霉烯类药物的敏感性和耐药性（PRIMERS III研究）
J Clin Microbiol. 2016 Dec 28;55(1):134-144. doi: 10.1128/JCM.01524-16. Print 2017 Jan.
10
Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models.溶血磷脂酰胆碱联合抗菌药物在实验性小鼠腹膜脓毒症和肺炎模型中对鲍曼不动杆菌的疗效
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4464-70. doi: 10.1128/AAC.02708-15. Print 2016 Aug.

本文引用的文献

1
Acinetobacter baumannii: an emerging multidrug-resistant threat.鲍曼不动杆菌：一种新出现的多重耐药威胁。
Expert Rev Anti Infect Ther. 2008 Jun;6(3):309-25. doi: 10.1586/14787210.6.3.309.
2
Acinetobacter infection.不动杆菌感染
N Engl J Med. 2008 Mar 20;358(12):1271-81. doi: 10.1056/NEJMra070741.
3
Comparative analysis of Acinetobacters: three genomes for three lifestyles.不动杆菌的比较分析：三种生活方式的三个基因组
PLoS One. 2008 Mar 19;3(3):e1805. doi: 10.1371/journal.pone.0001805.
4
Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii.鲍曼不动杆菌自诱导物合成酶的分离与鉴定
J Bacteriol. 2008 May;190(9):3386-92. doi: 10.1128/JB.01929-07. Epub 2008 Feb 15.
5
Reduction of disinfectant bactericidal activities in clinically isolated Acinetobacter species in the presence of organic material.在存在有机物质的情况下，临床分离的不动杆菌属物种中消毒剂杀菌活性的降低。
J Antimicrob Chemother. 2008 Mar;61(3):568-76. doi: 10.1093/jac/dkm498. Epub 2008 Jan 12.
6
Biofilm formation in Acinetobacter baumannii: associated features and clinical implications.鲍曼不动杆菌生物膜形成：相关特征及临床意义
Clin Microbiol Infect. 2008 Mar;14(3):276-8. doi: 10.1111/j.1469-0691.2007.01916.x. Epub 2008 Jan 10.
7
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.医院中日益严重的威胁：多重耐药鲍曼不动杆菌。
Nat Rev Microbiol. 2007 Dec;5(12):939-51. doi: 10.1038/nrmicro1789.
8
Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces.鲍曼不动杆菌多重耐药临床分离株形成生物膜并黏附于上皮细胞表面的能力。
Clin Microbiol Infect. 2008 Jan;14(1):49-54. doi: 10.1111/j.1469-0691.2007.01842.x. Epub 2007 Nov 13.
9
Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice.中性粒细胞在小鼠抵御鲍曼不动杆菌呼吸道感染的宿主抵抗力中发挥重要作用。
Infect Immun. 2007 Dec;75(12):5597-608. doi: 10.1128/IAI.00762-07. Epub 2007 Oct 1.
10
Global challenge of multidrug-resistant Acinetobacter baumannii.多重耐药鲍曼不动杆菌的全球挑战
Antimicrob Agents Chemother. 2007 Oct;51(10):3471-84. doi: 10.1128/AAC.01464-06. Epub 2007 Jul 23.